These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models. Chen M, Ma T, Li J, Zhang HJ, Li Q, Wang JJ, Sang T, Cao CL, Cui XW. Med Sci Monit; 2021 Feb 08; 27():e929913. PubMed ID: 33556045 [Abstract] [Full Text] [Related]
4. Additional value of the ratio of serum total testosterone to total prostate-specific antigen in the diagnosis of prostate cancer in a Chinese population. Xu L, Hu X, Zhu Y, Lu J, Xu Y, Wang G, Guo J. Andrologia; 2018 Mar 08; 50(2):. PubMed ID: 28752596 [Abstract] [Full Text] [Related]
12. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong WT, Ng CF, Wong KL. PLoS One; 2016 Feb 08; 11(9):e0162217. PubMed ID: 27598335 [Abstract] [Full Text] [Related]
13. MMP26: A potential biomarker for prostate cancer. Cheng T, Li F, Wei R, Lv MQ, Zhou Y, Dai Y, Yuan Y, Jiang GY, Ma D, Gao QL. J Huazhong Univ Sci Technolog Med Sci; 2017 Dec 08; 37(6):891-894. PubMed ID: 29270749 [Abstract] [Full Text] [Related]
14. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL. Kwiatkowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, Tscholl R. Urology; 1998 Sep 08; 52(3):360-5. PubMed ID: 9730444 [Abstract] [Full Text] [Related]
15. Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression. Wu T, Kasper S, Wong RM, Bracken B. Clin Genitourin Cancer; 2020 Apr 08; 18(2):e174-e179. PubMed ID: 31899150 [Abstract] [Full Text] [Related]
16. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies. Haese A, Graefen M, Steuber T, Becker C, Noldus J, Erbersdobler A, Huland E, Huland H, Lilja H. J Urol; 2003 Dec 08; 170(6 Pt 1):2269-73. PubMed ID: 14634394 [Abstract] [Full Text] [Related]
20. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction. Straub B, Müller M, Krause H, Schrader M, Goessl C, Heicappell R, Miller K. Urology; 2001 Nov 08; 58(5):815-20. PubMed ID: 11711374 [Abstract] [Full Text] [Related] Page: [Next] [New Search]